735 related articles for article (PubMed ID: 18990204)
1. Development of spasticity with age in a total population of children with cerebral palsy.
Hägglund G; Wagner P
BMC Musculoskelet Disord; 2008 Nov; 9():150. PubMed ID: 18990204
[TBL] [Abstract][Full Text] [Related]
2. Hand function in cerebral palsy. Report of 367 children in a population-based longitudinal health care program.
Arner M; Eliasson AC; Nicklasson S; Sommerstein K; Hägglund G
J Hand Surg Am; 2008 Oct; 33(8):1337-47. PubMed ID: 18929198
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of botulinum toxin A in children with cerebral palsy.
Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
[TBL] [Abstract][Full Text] [Related]
4. Passive muscle properties are altered in children with cerebral palsy before the age of 3 years and are difficult to distinguish clinically from spasticity.
Willerslev-Olsen M; Lorentzen J; Sinkjaer T; Nielsen JB
Dev Med Child Neurol; 2013 Jul; 55(7):617-23. PubMed ID: 23517272
[TBL] [Abstract][Full Text] [Related]
5. Spasticity of the gastrosoleus muscle is related to the development of reduced passive dorsiflexion of the ankle in children with cerebral palsy: a registry analysis of 2,796 examinations in 355 children.
Hägglund G; Wagner P
Acta Orthop; 2011 Dec; 82(6):744-8. PubMed ID: 21895507
[TBL] [Abstract][Full Text] [Related]
6. The relationship between clinical measurements and gait analysis data in children with cerebral palsy.
Domagalska M; Szopa A; Syczewska M; Pietraszek S; Kidoń Z; Onik G
Gait Posture; 2013 Sep; 38(4):1038-43. PubMed ID: 23810569
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
8. A clinical measurement to quantify spasticity in children with cerebral palsy by integration of multidimensional signals.
Bar-On L; Aertbeliën E; Wambacq H; Severijns D; Lambrecht K; Dan B; Huenaerts C; Bruyninckx H; Janssens L; Van Gestel L; Jaspers E; Molenaers G; Desloovere K
Gait Posture; 2013 May; 38(1):141-7. PubMed ID: 23218728
[TBL] [Abstract][Full Text] [Related]
9. [Rhizotomy for children with severe spastic cerebral palsy].
Illum NO; Torp-Pedersen L; Midholm S; Selmar PE; Simesen K
Ugeskr Laeger; 2006 Feb; 168(8):785-9. PubMed ID: 16499843
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
11. Roles of reflex activity and co-contraction during assessments of spasticity of the knee flexor and knee extensor muscles in children with cerebral palsy and different functional levels.
Pierce SR; Barbe MF; Barr AE; Shewokis PA; Lauer RT
Phys Ther; 2008 Oct; 88(10):1124-34. PubMed ID: 18703677
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of children with cerebral palsy after selective posterior rhizotomy with intensive physiotherapy or physiotherapy alone.
Mäenpää H; Salokorpi T; Jaakkola R; Blomstedt G; Sainio K; Merikanto J; von Wendt L
Neuropediatrics; 2003 Apr; 34(2):67-71. PubMed ID: 12776226
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive stretch reflexes, co-contraction, and muscle weakness in children with cerebral palsy.
Poon DM; Hui-Chan CW
Dev Med Child Neurol; 2009 Feb; 51(2):128-35. PubMed ID: 19018843
[TBL] [Abstract][Full Text] [Related]
14. The effects of muscle-tendon surgery on dynamic electromyographic patterns and muscle tone in children with cerebral palsy.
Dreher T; Brunner R; Vegvari D; Heitzmann D; Gantz S; Maier MW; Braatz F; Wolf SI
Gait Posture; 2013 Jun; 38(2):215-20. PubMed ID: 23228624
[TBL] [Abstract][Full Text] [Related]
15. The effect of adding homeopathic treatment to rehabilitation on muscle tone of children with spastic cerebral palsy.
Sajedi F; Alizad V; Alaeddini F; Fatemi R; Mazaherinezhad A
Complement Ther Clin Pract; 2008 Feb; 14(1):33-7. PubMed ID: 18243940
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of spasticity in children with cerebral palsy using Ashworth and Tardieu Scales compared with laboratory measures.
Alhusaini AA; Dean CM; Crosbie J; Shepherd RB; Lewis J
J Child Neurol; 2010 Oct; 25(10):1242-7. PubMed ID: 20223745
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
19. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
20. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
